Expression of vascular endothelial growth factor and its receptors in rats with protein-overload nephrosis.

BACKGROUND Based on the fact that vascular endothelial growth factor (VEGF) increases vascular permeability, it is speculated that VEGF might be involved in the development of proteinuria, although this remains unconfirmed. The production and site of action of VEGF remains unclear in nephrotic renal diseases. METHODS Non-radioactive in situ hybridization was performed to examine the expression of VEGF mRNA and its receptors, flt-1 and KDR/flk-1, in a rat model of nephrosis induced by intraperitoneal injection of bovine serum albumin (BSA). Saline injected rats were served as control animals. RESULTS Neither morphological changes nor deposition of immunoglobulin or complement were observed in our model. Proteinuria developed, reaching a maximum level in rats injected with BSA for 3 days, followed by persistent proteinuria until day 14. The expression of mRNA for VEGF and the two receptors was markedly upregulated in glomeruli of BSA-induced nephritis compared with the control group. VEGF mRNA was localized in glomerular cells, including cells in mesangium, visceral and parietal epithelial cells. In contrast, flt-1 mRNA and KDR/flk-1 mRNA were expressed on glomerular endothelial cells and cells in mesangium. The ratio of glomerular cells positive for VEGF mRNA and its receptors mRNA increased proportionately with the severity of proteinuria. Immunohistochemistry for ED-1 and proliferating cell nuclear antigen showed no significant increase in infiltrating macrophage or cellular proliferation. CONCLUSIONS Our results suggest that altered glomerular expression of VEGF and its receptors is not associated with proliferation of endothelial cells, but rather with proteinuria in BSA-induced nephritis in rats. VEGF may play a different role in different renal diseases.

[1]  K. Shulman,et al.  Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases. , 1996, Journal of the American Society of Nephrology : JASN.

[2]  T. Koji,et al.  Recent advances in molecular histochemical techniques: in situ hybridization and southwestern histochemistry. , 1996, Journal of electron microscopy.

[3]  C. Alpers,et al.  Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis. , 1995, The American journal of pathology.

[4]  H. Gröne,et al.  Expression of vascular endothelial growth factor in renal vascular disease and renal allografts , 1995, The Journal of pathology.

[5]  T. Shirasawa,et al.  Protein tyrosine kinases expressed in glomeruli and cultured glomerular cells: Flt-1 and VEGF expression in renal mesangial cells. , 1995, Biochemical and biophysical research communications.

[6]  F. Marumo,et al.  Glomerular endothelial cells in culture express and secrete vascular endothelial growth factor. , 1994, The American journal of physiology.

[7]  D. Connolly,et al.  Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor. , 1993, Kidney international.

[8]  E. Oldfield,et al.  Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. , 1993, The American journal of physiology.

[9]  E. Manseau,et al.  Vascular permeability factor mRNA and protein expression in human kidney. , 1992, Kidney international.

[10]  H. Abboud Growth factors and the mesangium. , 1992, Journal of the American Society of Nephrology : JASN.

[11]  N. Ferrara,et al.  Molecular and biological properties of the vascular endothelial growth factor family of proteins. , 1992, Endocrine reviews.

[12]  D. Connolly Vascular permeability factor: A unique regulator of blood vessel function , 1991, Journal of cellular biochemistry.

[13]  N. Copeland,et al.  A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. Eddy,et al.  Identification of a new endothelial cell growth factor receptor tyrosine kinase. , 1991, Oncogene.

[15]  K. Resch,et al.  Regulation of mesangial cell proliferation. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  T. Koji,et al.  Localization In Situ of Specific mRNA Using Thymine‐Thymine Dimerized DNA Probes , 1990, Acta pathologica japonica.

[17]  M. Shibuya,et al.  Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. , 1990, Oncogene.

[18]  H. Dvorak,et al.  Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. , 1988, The American journal of pathology.

[19]  H. Dvorak,et al.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.

[20]  G. Whipple,et al.  PROTEINURIA RELATED TO HYPERPROTEINEMIA IN DOGS FOLLOWING PLASMA GIVEN PARENTERALLY , 1948, The Journal of experimental medicine.